CVKD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CVKD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cadrenal Therapeutics's Cash Flow for Lease Financing for the three months ended in Jun. 2024 was $0.00 Mil. Cadrenal Therapeutics's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.
Compared with last quarter ($0.00 Mil in Mar. 2024 ), Cadrenal Therapeutics's Cash Flow for Lease Financing remained the same in Jun. 2024 ($0.00 Mil).
The historical data trend for Cadrenal Therapeutics's Cash Flow for Lease Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cadrenal Therapeutics Annual Data | |||||
Trend | Dec22 | Dec23 | |||
Cash Flow for Lease Financing | - | - |
Cadrenal Therapeutics Quarterly Data | ||||||||||
Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Cash Flow for Lease Financing | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | - | - |
Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.
Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Cadrenal Therapeutics's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
John Raymond Murphy | director | 233 S PATTERSON AVE, SPRINGFIELD MO 65802 |
Quang X Pham | director, 10 percent owner, officer: CEO and Chairman | 89 MELROSE DRIVE, MISSION VIEJO CA 92692 |
Robert Lisicki | director | C/O ARENA PHARMACEUTICALS, INC., 6154 NANCY RIDGE DRIVE, SAN DIEGO CA 92121 |
Douglas W Losordo | officer: Chief Medical Officer | 13 FOX MEADOW RD, SCARSDALE NY 10583 |
Steven Zelenkofske | director | 120 MOUNTAIN VIEW BOULEVARD, BASKING RIDGE NJ 07920 |
Matthew K Szot | officer: Chief Financial Officer | 802 NORTH DOUTY STREET, HANFORD CA 93230 |
Glynn Wilson | director | 2483 NE JULEP STREET, ISSAQUAH WA 98029 |
From GuruFocus
By PRNewswire • 10-09-2023
By PRNewswire • 07-12-2023
By PRNewswire • 07-14-2023
By PRNewswire PRNewswire • 03-30-2023
By PRNewswire • 09-05-2023
By PRNewswire • 11-30-2023
By PRNewswire PRNewswire • 05-10-2023
By PRNewswire • 08-10-2023
By PRNewswire • 08-28-2023
By PRNewswire PRNewswire • 02-08-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.